Literature DB >> 23839571

Background and design of the profiling biobehavioral responses to mechanical support in advanced heart failure study.

Christopher S Lee1, James O Mudd, Jill M Gelow, Thuan Nguyen, Shirin O Hiatt, Jennifer K Green, Quin E Denfeld, Julie T Bidwell, Kathleen L Grady.   

Abstract

BACKGROUND: Unexplained heterogeneity in response to ventricular assist device (VAD) implantation for the management of advanced heart failure impedes our ability to predict favorable outcomes, provide adequate patient and family education, and personalize monitoring and symptom management strategies. The purpose of this article was to describe the background and the design of a study entitled "Profiling Biobehavioral Responses to Mechanical Support in Advanced Heart Failure" (PREMISE). STUDY DESIGN AND METHODS: PREMISE is a prospective cohort study designed to (1) identify common and distinct trajectories of change in physical and psychological symptom burden; (2) characterize common trajectories of change in serum biomarkers of myocardial stress, systemic inflammation, and endothelial dysfunction; and (3) quantify associations between symptoms and biomarkers of pathogenesis in adults undergoing VAD implantation. Latent growth mixture modeling, including parallel process and cross-classification modeling, will be used to address the study aims and will entail identifying trajectories, quantifying associations between trajectories and both clinical and quality-of-life outcomes, and identifying predictors of favorable symptom and biomarker responses to VAD implantation.
CONCLUSIONS: Research findings from the PREMISE study will be used to enhance shared patient and provider decision making and to shape a much-needed new breed of interventions and clinical management strategies that are tailored to differential symptom and pathogenic responses to VAD implantation.

Entities:  

Mesh:

Year:  2014        PMID: 23839571      PMCID: PMC3885612          DOI: 10.1097/JCN.0b013e318299fa09

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  69 in total

1.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

2.  Quality of life with an implanted left ventricular assist device.

Authors:  A J Moskowitz; A D Weinberg; M C Oz; D L Williams
Journal:  Ann Thorac Surg       Date:  1997-12       Impact factor: 4.330

3.  The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012.

Authors:  Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2012-10       Impact factor: 10.247

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

5.  Quality of life outcomes after heart transplantation in individuals bridged to transplant with ventricular assist devices.

Authors:  M A Dew; R L Kormos; S Winowich; R C Harris; E A Stanford; L Carozza; B P Griffith
Journal:  J Heart Lung Transplant       Date:  2001-11       Impact factor: 10.247

Review 6.  Advanced heart failure: a call to action.

Authors:  Stuart D Russell; Leslie W Miller; Francis D Pagani
Journal:  Congest Heart Fail       Date:  2008 Nov-Dec

7.  Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation.

Authors:  Jeremiah G Allen; Eric S Weiss; Justin M Schaffer; Nishant D Patel; Susan L Ullrich; Stuart D Russell; Ashish S Shah; John V Conte
Journal:  J Heart Lung Transplant       Date:  2009-10-17       Impact factor: 10.247

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure.

Authors:  Wei-Hsian Yin; Jaw-Wen Chen; Hsu-Lung Jen; Meng-Cheng Chiang; Wen-Pin Huang; An-Ning Feng; Shing-Jong Lin; Mason Shing Young
Journal:  Eur J Heart Fail       Date:  2003-08       Impact factor: 15.534

10.  Patterns of Change in Cognitive Function over Six Months in Adults with Chronic Heart Failure.

Authors:  Barbara Riegel; Christopher S Lee; Dale Glaser; Stephen T Moelter
Journal:  Cardiol Res Pract       Date:  2012-08-15       Impact factor: 1.866

View more
  14 in total

1.  A longitudinal comparison of health-related quality of life in rural and urban recipients of left ventricular assist devices.

Authors:  Windy W Alonso; Kenneth M Faulkner; Bunny J Pozehl; Judith E Hupcey; Lisa A Kitko; Christopher S Lee
Journal:  Res Nurs Health       Date:  2020-07-06       Impact factor: 2.228

2.  Implant Strategy-Specific Changes in Symptoms in Response to Left Ventricular Assist Devices.

Authors:  Christopher S Lee; Jill M Gelow; Christopher V Chien; Shirin O Hiatt; Julie T Bidwell; Quin E Denfeld; Kathleen L Grady; James O Mudd
Journal:  J Cardiovasc Nurs       Date:  2018 Mar/Apr       Impact factor: 2.083

3.  Comparative symptom biochemistry between moderate and advanced heart failure.

Authors:  Christopher S Lee; Quin E Denfeld; Bradley E Aouizerat; Corrine Y Jurgens; Christopher V Chien; Emily Aarons; Jill M Gelow; Shirin O Hiatt; James O Mudd
Journal:  Heart Lung       Date:  2018-10-09       Impact factor: 2.210

4.  Exploring the relationship between β-adrenergic receptor kinase-1 and physical symptoms in heart failure.

Authors:  Quin E Denfeld; James O Mudd; Wohaib Hasan; Jill M Gelow; Shirin O Hiatt; Kerri Winters-Stone; Christopher S Lee
Journal:  Heart Lung       Date:  2018-05-24       Impact factor: 2.210

5.  Quality of Life, Depression, and Anxiety in Ventricular Assist Device Therapy: Longitudinal Outcomes for Patients and Family Caregivers.

Authors:  Julie T Bidwell; Karen S Lyons; James O Mudd; Jill M Gelow; Christopher V Chien; Shirin O Hiatt; Kathleen L Grady; Christopher S Lee
Journal:  J Cardiovasc Nurs       Date:  2017 Sep/Oct       Impact factor: 2.083

6.  Identifying unique profiles of perceived dyspnea burden in heart failure.

Authors:  Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Karen S Lyons; Jessica Harman Thompson; Christopher S Lee
Journal:  Heart Lung       Date:  2020-05-18       Impact factor: 2.210

7.  Sympathetic Markers are Different Between Clinical Responders and Nonresponders After Left Ventricular Assist Device Implantation.

Authors:  Quin E Denfeld; Christopher S Lee; William R Woodward; Shirin O Hiatt; James O Mudd; Beth A Habecker
Journal:  J Cardiovasc Nurs       Date:  2019 Jul/Aug       Impact factor: 2.083

8.  Adverse events in patients with a left ventricular assist device: are patient-reported outcomes affected?

Authors:  Jessica Harman Thompson; Kenneth Faulkner; Christopher Lee
Journal:  Eur J Cardiovasc Nurs       Date:  2022-04-09       Impact factor: 3.593

9.  Exploring gender differences in trajectories of clinical markers and symptoms after left ventricular assist device implantation.

Authors:  Quin E Denfeld; Kenneth M Faulkner; Mary Roberts Davis; Beth A Habecker; Christopher V Chien; Jill M Gelow; James O Mudd; Shirin O Hiatt; Kathleen L Grady; Christopher S Lee
Journal:  Eur J Cardiovasc Nurs       Date:  2021-10-27       Impact factor: 3.593

10.  Psychometric Testing of the Control Attitudes Scale-Revised for Patients With a Left Ventricular Assist Device.

Authors:  Jessica Harman Thompson; Debra Moser; Christopher S Lee
Journal:  J Cardiovasc Nurs       Date:  2022-03-24       Impact factor: 2.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.